| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ALHC | Common Stock | Award | $0 | +140K | +44.1% | $0.00 | 458K | Mar 13, 2024 | Direct | F1 |
| transaction | ALHC | Common Stock | Sale | -$21.2K | -4.33K | -0.94% | $4.89 | 454K | Mar 15, 2024 | Direct | F2, F3 |
| Id | Content |
|---|---|
| F1 | Represents (i) 70,000 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date; (ii) 18,000 fully vested shares of Common Stock granted as a discretionary award to the reporting person by the Board of Directors; and (iii) 52,190 fully vested shares of Common Stock granted in lieu of cash settlement of the annual incentive award earned by the reporting person for the 2023 fiscal year. |
| F2 | Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. |
| F3 | The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $4.77 to $5.06. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. |